SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 12:36 pm Sale | 2022-12-31 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -111,513 (Position Closed) | Filing |
| 2021-11-29 4:39 pm Purchase | 2021-11-18 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 111,513 6.000% | 111,513 (New Position) | Filing |